High mobility group proteins 1 and 2 recognize chromium-damaged DNA

Carcinogenesis

Volumn 18, Issue 2, 1997, Pages 371-375

  Wang, Jian Fei ^a   Bashir, Muhammad ^a   Engelsberg, Beatrice N ^a   Witmer, Charlotte ^b   Rozmiarek, Harry ^a   Billings, Paul C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CHROMIC ACID; CHROMIUM; CHROMIUM CHLORIDE; DNA; HIGH MOBILITY GROUP PROTEIN;

ARTICLE; BINDING AFFINITY; CARCINOGEN DNA INTERACTION; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; ELECTROPHORETIC MOBILITY; MOLECULAR RECOGNITION; PRIORITY JOURNAL;

ANIMALS; CATTLE; CHLORIDES; CHROMIUM; CHROMIUM COMPOUNDS; DNA; DNA ADDUCTS; DNA DAMAGE; HIGH MOBILITY GROUP PROTEINS; HL-60 CELLS; HUMANS;

EID: 0031426679     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.2.371     Document Type: Article

References (26)

1. IARC (1990) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 49, Chromium, Nickel and Welding. International Agency for Research on Cancer, Lyon, France, pp. 19-527.
2. Cohen, M.D., Kargacin, B., Klein, C.B. and Costa, M. (1993) Mechanisms of chromium carcinogenicity and toxicity. Crit. Rev. Toxicol., 23, 255-281.
3. Snow, E.T. (1992) Metal carcinogenesis: mechanistic implications. Pharmacol. Ther., 53, 31-65.
4. Witmer, C. (Ed.) (1991) The chromium problem: research needs and risk assessment. Environ. Hlth Perspect., 92, 3-144.
5. Biederman, K.A. and Landolph, J.R. (1990) Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis and anchorage independence in diploid human fibroblasts. Cancer Res., 50, 7835-7842.
6. De Flora, S., Bagnasco, M., Serra, D. and Zanacchi, P. (1990) Genotoxicity of chromium compounds. A review. Mutat. Res., 238, 99-172.
7. Katz, S.A. and Salem, H. (1993) The toxicology of chromium with respect to its chemical speciation: a review. J. Appl. Toxicol., 13, 217-224.
8. Witmer, C., Faria, E., Park, H.S., Sadrieh, N., Yurkow, E., O'Connell, S., Sirak, A. and Schleyer, H. (1994) In vivo effects of chromium. Environ. Hlth Perspect., 102 (suppl. 3), 169-176.
9. Ye, J., Zhang, X., Young, H.A., Mao, Y. and Shi, X. (1995) Chromium(VI)-induced nuclear factor-κB activation in intact cells via free radical reactions. Carcinogenesis, 16, 2401-2405.
10. Bridgewater, L.C., Manning, F.C., Woo, E.S. and Patierno, S.R. (1994) DNA polymerase arrest by adducted trivalent chromium. Mol. Carcinogen., 9, 122-133.
11. Bustin, M., Lehn, D.A. and Landsman, D. (1990) Structural features of the HMG chromosomal proteins and their genes. Biochim. Biophys. Acta, 1049, 231-243.
12. Read, C.M., Cary, P.D., Crane-Robinson, C., Driscoll, P.C., Carrillo, M.O.M. and Norman, D.G. (1995) The structure of the HMG box and its interaction with DNA. In Eckstein, F. and Lilley, D.M.J. (eds), Nucleic Acids and Molecular Biology. Springer Verlag, Berlin, Vol. 9, pp. 222-250.
13. Hughes, E.N., Engelsberg, B.N. and Billings, P.C. (1992) Purification of nuclear proteins that bind to cisplatin-damaged DNA: identity with high mobility group proteins 1 and 2. J. Biol. Chem., 267, 13 520-13 527.
14. Chu, G. (1994) Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J. Biol. Chem., 269, 787-790.
15. Olesik, J.W. (1991) Elemental analysis using ICP-OES and ICP/MS. Anal. Chem., 63, 12A-21A.
16. Chodosh, L.A. (1993) Mobility shift DNA-binding assay using gel electrophoresis. In Ausubel, F.M. et al. (eds), Current Protocols in Molecular Biology. Wiley Interscience, New York, NY, pp. 12.2.1-12.2.10.
17. Billings, P.C., Davis, R.J., Engelsberg, B.N., Skov, K.A. and Hughes, E.N. (1992) Characterization of High mobility group protein binding to cisplatin-damaged DNA. Biochem. Biophys. Res. Commun., 188, 1286-1294.
18. Chao, J.C., Wan, X.S., Engelsberg, B.N., Rothblum, L.I. and Billings, P.C. (1996) Intracellular distribution of HMG1, HMG2 and UBF change following treatment with cisplatin. Biochim. Biophys. Acta, 1307, 213-219.
19. Harlow, E. and Lane, D. (1988) Immunoblotting. In Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 471-510.
20. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of bacteriophage T4. Nature, 227, 680-685.
21. Baxter, J.D. and Funder, J.W. (1979) Hormone receptors. New Engl. J. Med., 301, 1149-1161.
22. Salles, B., Provot, C., Calsou, P., Hennebelle, I., Gosset, I., and Fournie, G.J. (1995) A chemiluminescent microplate assay to detect DNA damage induced by genotoxic treatments. Anal. Biochem., 232, 37-42.
23. +. Biophys. Chem., 35, 179-188.
24. Reed, E. (1993) Platinum analogs. In DeVita, V.T., Hellman, S. and Rosenberg, S.A. (eds), Cancer, Principles and Practice of Oncology. J.B. Lippincott, Philadelphia, PA, pp. 390-399.
25. Takahara, P.M., Rosenzweig, A.C., Frederick, C.A. and Lippard, S.J. (1995) Crystal structure of double stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature, 377, 649-652.
26. Blankenship, L.J., Manning, F.C., Orenstein, J.M. and Patierno, S.R. (1994) Apoptosis is the mode of cell death caused by carcinogenic chromium. Toxicol. Appl. Pharmacol., 126, 75-83.